BUDGET IMPACT ANALYSIS OF ABIRATERONE ACETATE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS PREVIOUSLY TREATED WITH DOCETAXEL FROM THE PERSPECTIVE OF THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM

被引：1
|
作者：
Vitale, V. [1 ]
Asano, E. [1 ]
Pereira, M. L. [1 ]
机构：
[1] Janssen Cilag Farmaceut, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1908
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A665 / A665
页数：1
相关论文
共 50 条
  • [21] Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer
    Auchus, Richard J.
    Yu, Margaret K.
    Nguyen, Suzanne
    Mundle, Suneel D.
    ONCOLOGIST, 2014, 19 (12): : 1231 - 1240
  • [22] Efficacy of abiraterone acetate in post-docetaxel castration-resistant prostate cancer
    Vogiatzi, Paraskevi
    Claudio, Pier Paolo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (07) : 1027 - 1030
  • [23] Experience of a Brazilian oncological center using abiraterone acetate in metastatic castration-resistant prostate cancer patients.
    Preto, Daniel D'Almeida
    Zucca, Luis Eduardo
    Carcano, Flavio Mavignier
    Zylberberg, Ricardo
    Neif, Joao Antonio Junior
    Fruet Filho, Carlos Alberto
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [24] Comparative analysis of the effectiveness of abiraterone before and after docetaxel in patients with metastatic castration-resistant prostate cancer
    Shameem, Raji
    Hamid, Muhammad Saad
    Xu, Kevin Y.
    Wu, Shenhong
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2015, 6 (04): : 64 - 72
  • [25] Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients
    Efstathiou, Eleni
    Titus, Mark
    Wen, Sijin
    Troncoso, Patricia
    Hoang, Anh
    Corn, Paul
    Prokhorova, Ina
    Araujo, John
    Dmuchowski, Carl
    Melhem-Bertrandt, Amal
    Patil, Shiva
    Logothetis, Christopher J.
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (01): : 119 - 127
  • [26] Abiraterone Acetate: A Review of Its Use in Patients with Metastatic Castration-Resistant Prostate Cancer
    Sheridan M. Hoy
    Drugs, 2013, 73 : 2077 - 2091
  • [27] Activity of Cabazitaxel After Docetaxel and Abiraterone Acetate Therapy in Patients With Castration-Resistant Prostate Cancer
    Sella, Avishay
    Sella, Tal
    Peer, Avivit
    Berger, Raanan
    Frank, Stephen Jay
    Gez, Eli
    Sharide, David
    Hayat, Henry
    Hanovich, Ekaterina
    Kovel, Svetlana
    Rosenbaum, Eli
    Neiman, Victoria
    Keizman, Daniel
    CLINICAL GENITOURINARY CANCER, 2014, 12 (06) : 428 - 432
  • [28] Abiraterone Acetate: A Review of Its Use in Patients with Metastatic Castration-Resistant Prostate Cancer
    Hoy, Sheridan M.
    DRUGS, 2013, 73 (18) : 2077 - 2091
  • [29] Activity of cabazitaxel following docetaxel and abiraterone acetate in patients with castration-resistant prostate cancer.
    Sella, Avishay
    Sella, Tal
    Peer, Avivit
    Berger, Raanan
    Frank, Stephen Jay
    Gez, Eliahu
    Sharid, David
    Hayat, Henry
    Rosenbaum, Eli
    Neiman, Victoria
    Keizman, Daniel
    Kovel, Svetlana
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer
    Sebastian Christoph Schmid
    Alexander Geith
    Alena Böker
    Robert Tauber
    Anna Katharina Seitz
    Markus Kuczyk
    Christoph von Klot
    Jürgen Erich Gschwend
    Axel Stuart Merseburger
    Margitta Retz
    Advances in Therapy, 2014, 31 : 234 - 241
12345